『2 Minutes with Joey - CRSP Stock News』のカバーアート

2 Minutes with Joey - CRSP Stock News

2 Minutes with Joey - CRSP Stock News

著者： 2 Minutes with Joey
無料で聴く

Two minutes with Joey on CRISPR Therapeutics (CRSP) - a quick daily recap of what the stock did today and why, in plain English. Information and entertainment only, not financial advice.Copyright 2 Minutes with Joey 社会科学
エピソード
  • CRSP Today - Jul 17: Six-Day Slide Continues

    CRSP Today - Jul 17: Six-Day Slide Continues
    2026/07/17
    Hey there! I’m Joey, your friendly neighborhood investor, here to break down what went down with CRISPR Therapeutics today. So, CRSP had a bit of a rough ride, closing down about half a percent. Yeah, it’s been a tough week.

    Now, here’s the scoop. CRISPR has been sliding for six straight days. That’s right, six! People are starting to wonder if it’s finally hit a cheap price, but honestly, it still feels like a slow bleed. Volume was way below average today, which means not a lot of folks were trading it. It’s like everyone’s holding their breath, waiting to see what happens next.

    So, why the drop? Well, a couple of articles pointed to some serious market pressure. It seems like investors are getting a little jittery about the biotech sector overall. Plus, some chatter around Intellia Therapeutics is stealing the spotlight. They’ve got some exciting stuff cooking in their pipeline, and it’s leaving CRISPR looking a bit overshadowed. Nobody really knows if this slide is just a temporary dip or something more serious.

    And speaking of the future, CRISPR’s got about $2.4 billion in cash on hand. So, they’re not exactly in a tight spot. That’s definitely something to keep in mind.

    To wrap it up, CRISPR’s been on a rough patch lately, and while some folks are wondering if it’s a good time to jump in, it’s still a wait-and-see game. Just remember, this is all for info and fun, not financial advice. Catch you later!
    続きを読む 一部表示
    1 分
  • CRSP Today - Jul 16: Six Red Days in a Row

    CRSP Today - Jul 16: Six Red Days in a Row
    2026/07/16
    Hey there! It’s Joey here, your go-to guy for breaking down the stock scene. I’ve been in the investing game for years, and today we’re checking out CRISPR Therapeutics, or CRSP. Not a great day for them — the stock got smoked, down over 5%. Ouch.

    So, what happened? It’s been a rough stretch lately, and today marked six straight red days for CRSP. That’s a total drop of about 18% over this little losing streak. A lot of folks are feeling the pressure and hitting that sell button fast. Volume was pretty low today too, which usually means people are a bit hesitant to jump in right now.

    Now, why’s this happening? Well, the chatter around the stock is a mix of uncertainty and some folks questioning its fair value. There's a report floating around suggesting CRISPR has about $2.4 billion in cash, which sounds solid, but it hasn’t really helped the stock price. Investors are likely worried about the overall market and the competition heating up in the CRISPR space. Plus, there’s been some buzz about Intellia Therapeutics, which has a hefty short interest. That might be pulling some eyes away from CRISPR and causing a bit of a standoff in the market.

    And just to keep you in the loop, there’s talk about CRISPR needing to show some solid progress soon to win back investor confidence. They’ve got to prove they can deliver results to turn this ship around.

    So, yeah, it’s been a tough time for CRISPR. If you’re watching this stock, just keep your eyes peeled. Remember, this is just info and entertainment, not financial advice. Thanks for hanging out with me today! Catch you later!
    続きを読む 一部表示
    2 分
  • CRSP Today - Jul 15: Six Red Days in a Row

    CRSP Today - Jul 15: Six Red Days in a Row
    2026/07/15
    Hey there! It’s Joey here. I’ve been investing for a while now, and I’m breaking down the day for you. So, let’s talk about CRISPR Therapeutics, or CRSP for short. Today, it was a bit of a mixed bag, but overall, it was a red day—up just a little, but still down big over the past week.

    So, here’s what went down. CRSP barely moved today, just a small uptick of around three-quarters of a percent. But man, it’s been rough lately. This stock has been on a six-day losing streak. Yeah, you heard that right—six days! It’s dropped about 18% during that time. That’s gotta hurt. People are feeling pretty jittery about it.

    Now, what’s behind this downward trend? Well, it seems like a combo of things. There’s been a lot of chatter about the overall market and how it’s affecting biotech stocks, especially gene-editing companies like CRISPR. Investors are getting a bit cautious, and when that happens, they tend to hit the sell button fast. Plus, there hasn’t been any major news or breakthroughs from CRISPR lately to boost confidence. So, folks are left wondering what’s next.

    On a slightly brighter note, there’s been some movement in the background. Canal Insurance just bought a new stake in CRISPR. While it’s not a game-changer, it does show that some investors see potential here, even if the stock’s been struggling. It’s like a glimmer of hope amidst the storm.

    Overall, it’s been a tough time for CRISPR, but that’s how the market rolls sometimes. Just remember, investing can be a wild ride. Keep your head up, and don’t let the ups and downs get you down. This is all for fun and info, not financial advice. Catch you later!
    続きを読む 一部表示
    2 分
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません